Inflammatory macrophage-derived plasminogen activator inhibitor-1 exacerbates inflammation through efferocytosis inhibition. [PDF]
Ibrahim AA +8 more
europepmc +1 more source
Advances in the Research of Hypoxia-Inducible Factor-1Alpha and Plasminogen Activator Inhibitor-1 in Vascular-Related Diseases. [PDF]
Xu X, Ge XH.
europepmc +1 more source
Plasminogen activator inhibitor-1, vaspin, and dietary inflammatory index in relation to cardiometabolic health in diabetic women. [PDF]
Kocabas S, Sanlier N.
europepmc +1 more source
Fibroblast circSamd4 promotes cardiac fibrosis via activating plasminogen activator inhibitor-1. [PDF]
Chen Y +13 more
europepmc +1 more source
Plasminogen Activator Inhibitor-1 Mediates Tolerance to Anti-PD-1 Immunotherapy in Non-Small Cell Lung Cancer. [PDF]
Sumii M +13 more
europepmc +1 more source
Plasminogen Activator Inhibitor-1 as a Therapeutic Target for Healthy Longevity, Immunosenescence, and Age-Related Disease: Translational Development of the Small-Molecule Inhibitor TM5614. [PDF]
Abdelhakim M, Miyata T.
europepmc +1 more source
Plasminogen activator inhibitor 1 promotes aortic aging-like pathophysiology in humans and mice. [PDF]
Khoddam A +15 more
europepmc +1 more source
Plasma Plasminogen Activator Inhibitor-1 as a Biomarker for Disease Activity and Pharmaco-Response Prediction in Pediatric Epilepsy: A Prospective Cohort Study. [PDF]
Xiao X +7 more
europepmc +1 more source
Plasminogen Activator Inhibitor-1 in Skin Malignancies: Therapeutic Implications of Its Inhibition. [PDF]
Fujimura T, Muto Y, Asano Y.
europepmc +1 more source
4G/5G polymorphism and plasma levels of plasminogen activator inhibitor-1 in essential thrombocythemia patients with driver mutational status. [PDF]
Zhang X, Guo X.
europepmc +1 more source

